vs
Side-by-side financial comparison of Andersons, Inc. (ANDE) and BALCHEM CORP (BCPC). Click either name above to swap in a different company.
Andersons, Inc. is the larger business by last-quarter revenue ($329.5M vs $270.7M, roughly 1.2× BALCHEM CORP). Andersons, Inc. runs the higher net margin — 20.5% vs 14.9%, a 5.6% gap on every dollar of revenue. On growth, BALCHEM CORP posted the faster year-over-year revenue change (8.1% vs -2.4%). BALCHEM CORP produced more free cash flow last quarter ($33.8M vs $-77.1M). Over the past eight quarters, BALCHEM CORP's revenue compounded faster (7.5% CAGR vs -1.8%).
The Andersons, Inc. is an American agribusiness established in 1947, that began as Andersons Truck Terminal (ATT) in the 1940s for the grain industry, headquartered in Maumee, Ohio. It is a diversified company rooted in agriculture that conducts business in the commodity merchandising, renewables, and plant nutrient sectors.
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
ANDE vs BCPC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $329.5M | $270.7M |
| Net Profit | $67.4M | $40.3M |
| Gross Margin | 70.3% | — |
| Operating Margin | 26.6% | 20.5% |
| Net Margin | 20.5% | 14.9% |
| Revenue YoY | -2.4% | 8.1% |
| Net Profit YoY | 49.6% | 8.7% |
| EPS (diluted) | — | $1.25 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $270.7M | ||
| Q4 25 | $329.5M | $263.6M | ||
| Q3 25 | $295.8M | $267.6M | ||
| Q2 25 | $535.0M | $255.5M | ||
| Q1 25 | $370.8M | $250.5M | ||
| Q4 24 | $337.5M | $240.0M | ||
| Q3 24 | $231.9M | $239.9M | ||
| Q2 24 | $492.5M | $234.1M |
| Q1 26 | — | $40.3M | ||
| Q4 25 | $67.4M | $39.2M | ||
| Q3 25 | $20.1M | $40.3M | ||
| Q2 25 | $7.9M | $38.3M | ||
| Q1 25 | $284.0K | $37.1M | ||
| Q4 24 | $45.1M | $33.6M | ||
| Q3 24 | $27.4M | $33.8M | ||
| Q2 24 | $36.0M | $32.1M |
| Q1 26 | — | — | ||
| Q4 25 | 70.3% | 35.6% | ||
| Q3 25 | 57.8% | 35.7% | ||
| Q2 25 | 29.6% | 36.4% | ||
| Q1 25 | 41.2% | 35.2% | ||
| Q4 24 | 63.1% | 36.0% | ||
| Q3 24 | 76.4% | 35.6% | ||
| Q2 24 | 35.6% | 35.5% |
| Q1 26 | — | 20.5% | ||
| Q4 25 | 26.6% | 19.8% | ||
| Q3 25 | 8.7% | 20.4% | ||
| Q2 25 | 4.6% | 20.1% | ||
| Q1 25 | 0.9% | 20.4% | ||
| Q4 24 | 19.9% | 19.8% | ||
| Q3 24 | 26.8% | 20.0% | ||
| Q2 24 | 11.6% | 19.6% |
| Q1 26 | — | 14.9% | ||
| Q4 25 | 20.5% | 14.9% | ||
| Q3 25 | 6.8% | 15.1% | ||
| Q2 25 | 1.5% | 15.0% | ||
| Q1 25 | 0.1% | 14.8% | ||
| Q4 24 | 13.4% | 14.0% | ||
| Q3 24 | 11.8% | 14.1% | ||
| Q2 24 | 7.3% | 13.7% |
| Q1 26 | — | $1.25 | ||
| Q4 25 | — | $1.21 | ||
| Q3 25 | $0.59 | $1.24 | ||
| Q2 25 | $0.23 | $1.17 | ||
| Q1 25 | $0.01 | $1.13 | ||
| Q4 24 | $1.31 | $1.03 | ||
| Q3 24 | $0.80 | $1.03 | ||
| Q2 24 | $1.05 | $0.98 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $98.3M | $72.9M |
| Total DebtLower is stronger | $560.0M | — |
| Stockholders' EquityBook value | $1.2B | $1.3B |
| Total Assets | $3.7B | $1.7B |
| Debt / EquityLower = less leverage | 0.45× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $72.9M | ||
| Q4 25 | $98.3M | $74.6M | ||
| Q3 25 | — | $65.1M | ||
| Q2 25 | — | $65.4M | ||
| Q1 25 | — | $49.9M | ||
| Q4 24 | $561.8M | $49.5M | ||
| Q3 24 | — | $73.7M | ||
| Q2 24 | — | $63.7M |
| Q1 26 | — | — | ||
| Q4 25 | $560.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $608.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $1.3B | ||
| Q4 25 | $1.2B | $1.3B | ||
| Q3 25 | $1.2B | $1.3B | ||
| Q2 25 | $1.4B | $1.3B | ||
| Q1 25 | $1.4B | $1.2B | ||
| Q4 24 | $1.4B | $1.1B | ||
| Q3 24 | $1.3B | $1.2B | ||
| Q2 24 | $1.3B | $1.1B |
| Q1 26 | — | $1.7B | ||
| Q4 25 | $3.7B | $1.7B | ||
| Q3 25 | $3.3B | $1.7B | ||
| Q2 25 | $3.4B | $1.7B | ||
| Q1 25 | $3.8B | $1.6B | ||
| Q4 24 | $4.1B | $1.6B | ||
| Q3 24 | $3.4B | $1.6B | ||
| Q2 24 | $3.3B | $1.6B |
| Q1 26 | — | — | ||
| Q4 25 | 0.45× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.45× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.2M | $40.1M |
| Free Cash FlowOCF − Capex | $-77.1M | $33.8M |
| FCF MarginFCF / Revenue | -23.4% | 12.5% |
| Capex IntensityCapex / Revenue | 21.5% | 2.3% |
| Cash ConversionOCF / Net Profit | -0.09× | 0.99× |
| TTM Free Cash FlowTrailing 4 quarters | $-56.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $40.1M | ||
| Q4 25 | $-6.2M | $67.3M | ||
| Q3 25 | $233.9M | $65.6M | ||
| Q2 25 | $299.3M | $47.3M | ||
| Q1 25 | $-350.0M | $36.5M | ||
| Q4 24 | $268.8M | $52.3M | ||
| Q3 24 | $-2.1M | $51.3M | ||
| Q2 24 | $304.4M | $45.0M |
| Q1 26 | — | $33.8M | ||
| Q4 25 | $-77.1M | — | ||
| Q3 25 | $167.0M | — | ||
| Q2 25 | $250.5M | — | ||
| Q1 25 | $-396.6M | — | ||
| Q4 24 | $212.9M | — | ||
| Q3 24 | $-40.0M | — | ||
| Q2 24 | $275.8M | — |
| Q1 26 | — | 12.5% | ||
| Q4 25 | -23.4% | — | ||
| Q3 25 | 56.5% | — | ||
| Q2 25 | 46.8% | — | ||
| Q1 25 | -106.9% | — | ||
| Q4 24 | 63.1% | — | ||
| Q3 24 | -17.2% | — | ||
| Q2 24 | 56.0% | — |
| Q1 26 | — | 2.3% | ||
| Q4 25 | 21.5% | — | ||
| Q3 25 | 22.6% | — | ||
| Q2 25 | 9.1% | — | ||
| Q1 25 | 12.6% | — | ||
| Q4 24 | 16.6% | — | ||
| Q3 24 | 16.3% | — | ||
| Q2 24 | 5.8% | — |
| Q1 26 | — | 0.99× | ||
| Q4 25 | -0.09× | 1.72× | ||
| Q3 25 | 11.61× | 1.63× | ||
| Q2 25 | 38.10× | 1.23× | ||
| Q1 25 | -1232.46× | 0.98× | ||
| Q4 24 | 5.96× | 1.56× | ||
| Q3 24 | -0.08× | 1.52× | ||
| Q2 24 | 8.46× | 1.40× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ANDE
| Specialty And Primary Nutrients | $137.1M | 42% |
| Premium Ingredients | $66.1M | 20% |
| Segment Reporting Reconciling Item Other | $63.2M | 19% |
| Other | $63.1M | 19% |
BCPC
Segment breakdown not available.
